I am a …
Matsuo Kiyonobu
My job carrier so far is summarized to have been an IT expert as well as management in safety(Pharmacovigilance) & PMS* (Post-Marketing Surveillance) business.
*PMS : Post-Marketing Surveillance (PMS) is a method of monitoring the safety of drugs and medical devices after they have been approved for marketing and used in the general population, as well as additional indications are added.
Under the direction of the Ministry of Health, Labour and Welfare (MHLW), marketing authorization holders (pharmaceutical companies and medical device manufacturers) conduct surveys of medical institutions (hospitals and clinics) and report their findings to the MHLW.
On behalf of Shuttle Bros., a young, just started venture business, our ambition is aiming at innovation in the business with AI Technology.
2022 Foundation of Shuttle Bros. Inc.
CEO: Pharmacovigilance business with AI technology
2012 - PV Next Co., Ltd.(present Syneos Health, Inc.)
Director: Foundation of PV Next Co., Ltd.
Pharmacovigilance business responsible
AI Service development (using Google BERT)
2002 - CAC Corporation (present EPS Corporation)
Business Director for Pharmacovigilance & Responsible head for the following
Systems and services related to Pharmacovigilance
Contract pharmacovigilance services
1989 - Digital Equipment Corporateion Japan (present DXC Technology Japan, Ltd.)
Software Devlopment Director. Clients: pharmaceutical companies.
Support System for Medical Representatives in Pharmaceutical industry
Support system for academic information
Pharmacovigilance System localized
Japan-U.S.-Europe Safety Information Sharing System for the two clients
Sankyo Co., Ltd.(present Daiichi Ssankyo Co.,Ltd.)
Fujisawa Pharmaceutical Co.,Ltd.(present Astellas Pharma Inc.)
1984 - MATSUO Bridge Co., LTD. (present IHI Infrastructure Systems Co.,Ltd.)
Engaged in structural analysis at the Bridge Design Department.
Publication
Differences in the Requirements of the Three Regions (Japan, the U.S., and Europe)
Post-marketing safety measures and post-marketing surveillance and review trends / co-author: